51 – 60 of 82
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing
(
- Contribution to journal › Article
-
Mark
Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort
(
- Contribution to journal › Article
-
Mark
Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort
(
- Contribution to journal › Article
-
Mark
Intrinsic subtypes and prognostic implications in epithelial ovarian cancer
(
- Thesis › Doctoral thesis (compilation)
- 2014
-
Mark
Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Panitumumab and Pegylated Liposomal Doxorubicin in Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-Type: The PaLiDo Study, a Phase II Nonrandomized Multicenter Study.
(
- Contribution to journal › Article
-
Mark
Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Discovery of Dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Cancer predisposing BARD1 mutations in breast-ovarian cancer families
(
- Contribution to journal › Article
-
Mark
Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study
(
- Contribution to journal › Article